VERTEX PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of VRTX for the last quarter is 42.81 B MXN, and it's 0.99% lower compared to the previous quarter. The net income of Q4 23 is 16.46 B MXN.